Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose MIRCERA administration in healthy Japanese adult males
jRCT1080221926Phase 1
- Sponsor
- Mitsubishi Chemical Group
- Start
- Sep 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Epoetin alfa RB in Uraemic Anaemia, sponsored by Mitsubishi Chemical Group.
02
Drugs
Epoetin alfa RB
03
Conditions
Uraemic Anaemia
Beyond the preview
Go deeper on jRCT1080221926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080221926.